303 related articles for article (PubMed ID: 29989047)
21. KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family.
Enkhbaatar Z; Terashima M; Oktyabri D; Tange S; Ishimura A; Yano S; Suzuki T
Cell Cycle; 2013 Jul; 12(13):2100-12. PubMed ID: 23759590
[TBL] [Abstract][Full Text] [Related]
22. KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/CCNE1 axis.
Chen B; Chen H; Lu S; Zhu X; Que Y; Zhang Y; Huang J; Zhang L; Zhang Y; Sun F; Wang J; Zhu J; Zhen Z; Zhang Y
Cell Death Dis; 2022 Apr; 13(4):354. PubMed ID: 35428764
[TBL] [Abstract][Full Text] [Related]
23. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma.
Li L; Shou H; Wang Q; Liu S
Gene; 2019 Apr; 694():76-82. PubMed ID: 30658067
[TBL] [Abstract][Full Text] [Related]
24. H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity.
He R; Xhabija B; Gopi LK; Kurup JT; Xu Z; Liu Z; Kidder BL
Oncogene; 2022 May; 41(21):2958-2972. PubMed ID: 35440714
[TBL] [Abstract][Full Text] [Related]
25. Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis.
Huang J; Jin S; Guo R; Wu W; Yang C; Qin Y; Chen Q; He X; Qu J; Yang Z
RNA; 2024 Mar; 30(4):435-447. PubMed ID: 38296629
[TBL] [Abstract][Full Text] [Related]
26. Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions.
Xue S; Lam YM; He Z; Zheng Y; Li L; Zhang Y; Li C; Mbadhi MN; Zheng L; Cheng Z; Liu Y; Wang X; Chan LC; Ng RK; Zhang J
Exp Hematol; 2020 Feb; 82():53-65. PubMed ID: 32007477
[TBL] [Abstract][Full Text] [Related]
27. AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer.
Khan MI; Hamid A; Rath S; Ateeq B; Khan Q; Siddiqui IA; Adhami VM; Choudhry H; Zamzami MA; Mukhtar H
Mol Cancer Ther; 2019 Feb; 18(2):356-363. PubMed ID: 30446585
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas.
Darvishi E; Slemmons K; Wan Z; Mitra S; Hou X; Hugues Parmentier J; Eddie Loh YH; Helman LJ
Neoplasia; 2020 Jul; 22(7):274-282. PubMed ID: 32464274
[TBL] [Abstract][Full Text] [Related]
29. A truncated and catalytically inactive isoform of KDM5B histone demethylase accumulates in breast cancer cells and regulates H3K4 tri-methylation and gene expression.
Di Nisio E; Licursi V; Mannironi C; Buglioni V; Paiardini A; Robusti G; Noberini R; Bonaldi T; Negri R
Cancer Gene Ther; 2023 Jun; 30(6):822-832. PubMed ID: 36697763
[TBL] [Abstract][Full Text] [Related]
30. Original Research: miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells.
Cui G; Liu D; Li W; Li Y; Liang Y; Shi W; Zhao S
Exp Biol Med (Maywood); 2017 Jan; 242(1):45-52. PubMed ID: 27480251
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer.
Yeh IJ; Esakov E; Lathia JD; Miyagi M; Reizes O; Montano MM
Sci Rep; 2019 Nov; 9(1):17663. PubMed ID: 31776402
[TBL] [Abstract][Full Text] [Related]
32. Coordinated regulation of retinoic acid signaling pathway by KDM5B and polycomb repressive complex 2.
Zhang Y; Liang J; Li Q
J Cell Biochem; 2014 Sep; 115(9):1528-38. PubMed ID: 24619877
[TBL] [Abstract][Full Text] [Related]
33. H3K4 demethylase KDM5B regulates global dynamics of transcription elongation and alternative splicing in embryonic stem cells.
He R; Kidder BL
Nucleic Acids Res; 2017 Jun; 45(11):6427-6441. PubMed ID: 28402433
[TBL] [Abstract][Full Text] [Related]
34. Increased Expression of Lysine-Specific Demethylase 5B (KDM5B) Promotes Tumor Cell Growth in Hep3B Cells and is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma.
Gong J; Yan S; Yu H; Zhang W; Zhang D
Med Sci Monit; 2018 Oct; 24():7586-7594. PubMed ID: 30353907
[TBL] [Abstract][Full Text] [Related]
35. CUX2/KDM5B/SOX17 Axis Affects the Occurrence and Development of Breast Cancer.
Li L; Zhu G; Tan K; Jiang L; Li Y; Zhu X; Lin Z; Zhang X; Chen J; Ma C
Endocrinology; 2022 Sep; 163(9):. PubMed ID: 35881915
[TBL] [Abstract][Full Text] [Related]
36. JARID1B deletion induced apoptosis in Jeko-1 and HL-60 cell lines.
Su H; Ma X; Huang Y; Han H; Zou Y; Huang W
Int J Clin Exp Pathol; 2015; 8(1):171-83. PubMed ID: 25755704
[TBL] [Abstract][Full Text] [Related]
37. The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential.
Wong SH; Goode DL; Iwasaki M; Wei MC; Kuo HP; Zhu L; Schneidawind D; Duque-Afonso J; Weng Z; Cleary ML
Cancer Cell; 2015 Aug; 28(2):198-209. PubMed ID: 26190263
[TBL] [Abstract][Full Text] [Related]
38. Histone demethylase KDM5B catalyzed H3K4me3 demethylation to promote differentiation of bone marrow mesenchymal stem cells into cardiomyocytes.
Wang Z; Zhong C; Li H
Mol Biol Rep; 2022 Aug; 49(8):7239-7249. PubMed ID: 35788877
[TBL] [Abstract][Full Text] [Related]
39. Novel KDM5B splice variants identified in patients with developmental disorders: Functional consequences.
Lebrun N; Mehler-Jacob C; Poirier K; Zordan C; Lacombe D; Carion N; Billuart P; Bienvenu T
Gene; 2018 Dec; 679():305-313. PubMed ID: 30217758
[TBL] [Abstract][Full Text] [Related]
40. KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
Li G; Kanagasabai T; Lu W; Zou MR; Zhang SM; Celada SI; Izban MG; Liu Q; Lu T; Ballard BR; Zhou X; Adunyah SE; Matusik RJ; Yan Q; Chen Z
Cancer Res; 2020 Nov; 80(21):4633-4643. PubMed ID: 32868382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
